A
EW icon

Argentarii’s Edwards Lifesciences EW Stock Holding History

Argentarii’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$855K Sell
10,678
-2,814
-21% -$232K 0.3% 77
2025
Q4 		$1.15M Sell
13,492
-524
-4% -$43K 0.37% 61
2025
Q3 		$1.09M Buy
14,016
+3,109
+29% +$243K 0.43% 50
2025
Q2 		$853K Sell
10,907
-1,825
-14% -$136K 0.39% 61
2025
Q1 		$923K Buy
12,732
+9,280
+269% +$664K 0.46% 58
2024
Q4 		$256K Buy
+3,452
New +$242K 0.13% 129

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Argentarii's EW Position: Q1 2026 in Review

Argentarii reduced its Edwards Lifesciences (EW) stake by 21% in Q1 2026, selling an estimated $232K and leaving 10,678 shares worth $855K. The position accounts for 0.3% of the portfolio, ranked #77.

Argentarii first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.15M in Q4 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Argentarii held 10,678 shares of Edwards Lifesciences worth $855K as of Q1 2026.
  • Argentarii sold 2,814 Edwards Lifesciences shares in Q1 2026, an estimated $232K.
  • Edwards Lifesciences made up 0.3% of Argentarii's portfolio in Q1 2026, its #77 holding.
  • Argentarii first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • Argentarii's Edwards Lifesciences position peaked at $1.15M in Q4 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Argentarii's 13F filing for Q1 2026, filed 12 May 2026.